Samuel V Alworth
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2017First federal award
$9.4MFederal grants as PI12 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
12 awards · $9.4M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 28, 2024 | NIH | SBIR Phase II Development of a SYF2 antisense oligonucleotide treatment for ALS and FTD | $1.4M | ACURASTEM INC |
| Jul 31, 2023 | NIH | SBIR Phase II Development of a SYF2 antisense oligonucleotide treatment for ALS and FTD | $1.5M | ACURASTEM INC |
| Sep 2, 2022 | NIH | SBIR Phase II Development of a PIKFYVE antisense oligonucleotide treatment for FTD | $76K | ACURASTEM INC |
| Aug 31, 2022 | NIH | SBIR Phase II Development of a PIKFYVE Antisense Oligonucleotide Treatment for FTD | $41K | ACURASTEM INC |
| Aug 16, 2022 | NIH | SBIR Phase II Development of a PIKFYVE antisense oligonucleotide treatment for FTD | $1.5M | ACURASTEM INC |
| Sep 10, 2021 | NIH | SBIR Phase II Development of a PIKFYVE antisense oligonucleotide treatment for FTD | $1.0M | ACURASTEM INC |
| Jun 10, 2021 | NIH | SBIR Phase II PIKFYVE antagonism as a therapy for C9ORF72-ALS/FTD | $533K | ACURASTEM INC |
| Jun 1, 2020 | NIH | SBIR Phase II PIKFYVE antagonism as a therapy for C9ORF72-ALS/FTD | $1.1M | ACURASTEM INC |
| Sep 19, 2019 | NIH | SBIR Phase II PIKFYVE antagonism as a therapy for C9ORF72-ALS/FTD | $1.3M | ACURASTEM INC |
| May 9, 2019 | NIH | SBIR Phase II PIKFYVE antagonism as a therapy for C9ORF72-ALS/FTD | $265K | ACURASTEM INC |
| Apr 26, 2018 | NIH | SBIR Phase II PIKFYVE antagonism as a therapy for C9ORF72-ALS/FTD | $433K | ACURASTEM INC |
| Sep 13, 2017 | NIH | SBIR Phase I Preserving cellular aspects of aging in patient-specific models of ALS | $225K | ACURASTEM INC |
Peer ranks
Federal funding#72
Awards as PI#86
Patents#273
Companies
- ACURASTEM INCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.